股票行情快报：迈得医疗（688310）2月25日主力资金净买入110.75万元

Group 1 - The core viewpoint of the news is that Maide Medical (688310) has shown a slight increase in stock price and a mixed performance in financial metrics for the third quarter of 2025, indicating potential growth opportunities despite some challenges in net profit [1][2]. Group 2 - As of February 25, 2026, Maide Medical's stock closed at 17.83 yuan, with a trading volume of 17,200 hands and a total transaction amount of 30.72 million yuan [1]. - The net inflow of main funds was 1.11 million yuan, accounting for 3.6% of the total transaction amount, while retail investors experienced a net outflow of 1.06 million yuan, representing 3.45% of the total transaction amount [1]. - For the first three quarters of 2025, Maide Medical reported a main revenue of 225 million yuan, a year-on-year increase of 2.31%, and a net profit attributable to shareholders of 8.84 million yuan, up 15.82% year-on-year [2]. - In Q3 2025, the company achieved a single-quarter main revenue of 83.64 million yuan, a year-on-year increase of 54.38%, and a net profit of 2.79 million yuan, up 224.07% year-on-year [2]. - The company's debt ratio stands at 29.86%, with a gross profit margin of 40.19% [2].